News on this topic
Medicare plans can cover Wegovy for patients with heart conditions: The federal government said that its prescription drug insurance for seniors will cover the ...
washingtonpost.com/business/2024/03/21/wegovy-medicare-part-d/
Medicare will cover Wegovy to reduce heart disease risk: Medicare will provide coverage for Wegovy for patients with an increased risk of heart attack ...
nbcnews.com/health/health-news/medicare-will-cover-wegovy-reduce-heart-disease-risk-rcna143479
Medicare allows coverage of weight-loss drugs for heart conditions: While Medicare bans the drugs for weight loss, it said enrollees can get coverage for other ...
axios.com/2024/03/21/medicare-wegovy-ozempic-weight-loss-drugs-allow
More articles on this subject
Previous
Medicare plans can cover Wegovy for patients with heart conditions: The federal government said that its prescription drug insurance for seniors will cover the ...
washingtonpost.com/business/2024/03/21/wegovy-medicare-part-d/
Medicare will cover Wegovy to reduce heart disease risk: Medicare will provide coverage for Wegovy for patients with an increased risk of heart attack ...
nbcnews.com/health/health-news/medicare-will-cover-wegovy-reduce-heart-disease-risk-rcna143479
Medicare allows coverage of weight-loss drugs for heart conditions: While Medicare bans the drugs for weight loss, it said enrollees can get coverage for other ...
axios.com/2024/03/21/medicare-wegovy-ozempic-weight-loss-drugs-allow
Wegovy to be covered by US Medicare for heart disease patients: Heart patients insured under the U.S. Medicare program would be covered for Novo Nordisk's ...
reuters.com/business/healthcare-pharmaceuticals/wegovy-be-covered-by-us-medicare-heart-disease-patients-2024-03-21/
The popular weight loss drug Wegovy will now be covered under Medicare — but not for weight loss
qz.com/wegovy-novo-nordisk-medicare-heart-1851356708
Paid articlePaid
Medicare Will Cover Wegovy, but Only for Patients With Serious Heart Risks: Roughly 42% of Americans are obese, making the U.S. a huge market for anti-obesity ...
gizmodo.com/wegovy-ozempic-cost-novo-nordisk-free-medicare-coverage-1851357184
Bird Flu Virus Found in One in Five US Milk Samples, FDA Says: Fragments of the bird flu virus have been found in about one fifth of commercial milk samples ...
bloomberg.com/news/articles/2024-04-26/bird-flu-virus-found-in-one-in-five-us-milk-samples-fda-says
Quick Glance: Key Insights on Bird Flu-Traced Milk Safety
- FDA confirms traces of bird flu in milk, but emphasizes low public risk.
- Although genetic material of the virus was found in milk, tests show no infectious or live form.
- Authorities have not conducted specific studies on bird flu inactivation in cow's milk through pasteurization.
- Experts stress that milk with bird flu traces is safe as long as it is pasteurized and sourced from infected cows.
US FDA approves Pfizer's gene therapy for rare bleeding disorder: The U.S. Food and Drug Administration approved Pfizer's gene therapy for hemophilia B on Friday ...
reuters.com/business/healthcare-pharmaceuticals/us-fda-approves-pfizers-gene-therapy-rare-bleeding-disorder-2024-04-26/
Quick Glance: FDA approves Pfizer’s gene therapy for hemophilia B
- The FDA has approved Pfizer's first gene therapy drug for a rare inherited bleeding disorder.
- Beqvez, a unique gene therapy drug by Pfizer, has been approved for adults with moderate to severe hemophilia B.
- The drug enables patients to produce Factor IX themselves to prevent and control bleeding.
- Pfizer is competing with a similar treatment from CSL Behring and planning more gene therapies for various genetic disorders.
Bird flu: traces detected in US milk; senators push for action: Colorado became the ninth U.S. state to report a dairy herd infected with bird flu on Friday as ...
reuters.com/world/us/us-fda-says-about-1-5-commercial-milk-samples-tested-positive-bird-flu-traces-2024-04-26/
Biden administration indefinitely postpones rule that would have banned menthol-flavored cigarettes
apnews.com/article/menthol-ban-fda-biden-cigarettes-smokers-e9a28fb0ac70fcb0ad8e106c42d4c951
Quick Glance: Biden administration faces delays in menthol cigarettes ban
- The planned implementation of a ban on menthol cigarettes in the US is expected to take 'significantly more time,' according to US Health and Human Services Secretary Xavier Becerra in a statement on Friday.
- In April 2022, the US Food and Drug Administration (FDA) initially announced the ban on the popular mint flavor, setting a deadline for August 2023. Final rules were sent to the White House Office of Management and Budget for review in October, with the status listed as 'pending.'
- According to the proposed FDA regulations, the manufacturing and sale of menthols would be prohibited, without direct regulation of smokers themselves.
- A prohibition on menthol cigarettes could potentially save up to 650,000 lives over the next 40 years, with a third of these lives being saved within the black community, as stated by the Campaign for Tobacco-Free Kids.
US Senate committee investigates pricing of Novo's Ozempic and Wegovy: A U.S. Senate committee said on Wednesday it had launched an investigation into the prices ...
reuters.com/business/healthcare-pharmaceuticals/us-senate-committee-investigates-pricing-novos-ozempic-wegovy-2024-04-24/
US FDA sends warning letter to Cardinal Health for marketing unapproved devices
reut.rs/4bawEqO
Quick Glance: US FDA issues warning to Cardinal Health for marketing unauthorized devices
- Following an inspection of its facility in Illinois, the US health regulatory body issued a warning letter to Cardinal Health for marketing and distributing unauthorized devices from a Chinese manufacturer.
- In 2023, the U.S. Food and Drug Administration advised against using certain syringes manufactured in China due to reports of leaks, breakages, and quality issues, and recently expanded the guidelines.
- Cardinal has not responded to a request for comment from Reuters. The inspection revealed that Cardinal was importing two types of syringes under the Monoject brand.
- These syringes are utilized for injecting or withdrawing fluids from the body, as well as administering fluids or medications through a patient's feeding tube. In November, the agency cautioned healthcare providers and facilities against using Cardinal's Monoject syringes with pain management and syringe pumps.
Alzheimer's drug adoption in US slowed by doctors' skepticism: Nine months into the U.S. launch of the first drug proven to slow the advance of Alzheimer's ...
reuters.com/business/healthcare-pharmaceuticals/alzheimers-drug-adoption-us-slowed-by-doctors-skepticism-2024-04-23/
Quick Glance: Alzheimer's Drug Uptake Hindered by Doctors' Skepticism in US
- The first drug to slow the progression of Alzheimer's, Leqembi by Eisai and Biogen, is facing resistance in the US from doctors who believe the treatment is futile.
- The requirements of Leqembi, such as additional diagnostic tests, twice-monthly infusions, and regular brain scans, have led to slow adoption as many doctors express concerns about efficacy, cost, and risks.
- Despite FDA approval and proven benefits in clinical trials, many doctors still have reservations about Leqembi, hindering the widespread use of the drug.
- The companies behind Leqembi are working to improve physician and patient education to increase acceptance of the medication, aiming to treat 100,000 patients by 2026.
FDA Approves Antibiotic to Treat Urinary Infections: Pivmecillinam, which has been used in Europe for decades, will become available next year to women 18 and ...
nytimes.com/2024/04/24/health/fda-urinary-tract-infection-antibiotic.html
Merck raises 2024 profit forecast on surging sales of cancer drug Keytruda: Merck & Co on Thursday raised its annual profit and revenue forecasts on the back of ...
reuters.com/business/healthcare-pharmaceuticals/merck-raises-2024-profit-forecast-strong-cancer-hpv-drugs-sales-2024-04-25/
Quick Glance: Merck boosts 2024 profit outlook due to Keytruda sales
- Merck & Co. raises annual profit and revenue forecasts based on double-digit growth for the blockbuster cancer drug Keytruda.
- Sales for 2024 are estimated to be between $63.1 billion and $64.3 billion, an increase from the previous forecast.
- Keytruda recorded $6.95 billion in sales in the first quarter, a 20% increase from the previous year.
- Merck also saw strong growth with its vaccine Gardasil, the drug Vaxneuvance, and a successful acquisition of Harpoon Therapeutics in the first quarter of 2024.
Inside Novo Nordisk, the Company Behind Ozempic and Wegovy: Novo Nordisk’s factories work nonstop turning out Ozempic and Wegovy, its blockbuster weight-loss ...
nytimes.com/2024/04/20/business/ozempic-novo-nordisk-wegovy.html
US FDA approves ImmunityBio's bladder cancer therapy: The U.S. health regulator approved on Monday ImmunityBio's combination therapy to treat a type of bladder ...
reuters.com/business/healthcare-pharmaceuticals/us-fda-approves-immunitybios-bladder-cancer-therapy-2024-04-22/
German watchdog approves Novo's acquisition of Cardior Pharmaceuticals: The German cartel office has approved a deal by Denmark's Novo Nordisk to purchase ...
reuters.com/business/healthcare-pharmaceuticals/german-watchdog-approves-novos-acquisition-cardior-pharmaceuticals-2024-04-18/
1 in 5 Pasteurized Milk Samples Show Traces of Bird Flu Virus: FDA : A nationwide survey found traces of the bird flu virus in 1 in 5 retail samples of ...
webmd.com/food-recipes/food-poisoning/news/20240426/1-in-5-pasteurized-milk-samples-traces-bird-flu-fda
Quick Glance: Unanswered Inquiries Regarding Advancing Avian Flu in U.S. Cows
- The advancing spread of avian flu in U.S. dairy cattle continues to raise numerous questions. Scientists emphasize the minimal risk to humans, but uncertainties persist regarding the dissemination and impact of the virus.
- Despite confirming the virus in nine states and over 30 herds, the actual scope of spread remains ambiguous due to insufficient testing.
- Researchers express concerns about potential public health implications, the infectivity of the virus in milk, and its transmission. Only one human infection has been officially recorded amid the ongoing outbreak.
- Experts hold differing views on the human risks as the virus persists among cows. The mutation possibility poses a potential threat to human health.
Solicitor General Elizabeth Prelogar again in the spotlight fighting the conservative Supreme Court on abortion
cnn.com/2024/04/24/politics/solicitor-general-elizabeth-prelogar-idaho-abortion/
Quick Glance: Supreme Court Divided on Emergency Abortion Access: Highlights
- The Supreme Court seems divided on access to emergency abortions in states with near-total bans.
- The 1986 Emergency Medical Treatment and Labor Act could impact abortion access in emergencies.
- The debate raises questions about fetal personhood and abortion rights conflict.
- The court's decision could affect abortion access in 14 states with strict abortion bans.
InnovationRx: Legislation Could Prevent Pharma Companies From Working With Chinese Contractors
forbes.com/sites/katiejennings/2024/04/17/innovationrx-legislation-could-prevent-pharma-companies-from-working-with-chinese-contractors/
Biden administration issues privacy rule protecting abortion: President Joe Biden's administration issued a final rule on Monday aimed at strengthening privacy ...
reuters.com/world/us/biden-administration-issues-privacy-rule-protecting-abortion-2024-04-22/
Plaintiffs' lawyers chosen to lead Ozempic litigation: A federal judge has appointed eight plaintiffs' lawyers to leadership roles in federal mass tort ...
reuters.com/legal/litigation/plaintiffs-lawyers-chosen-lead-ozempic-litigation-2024-04-24/
National Drug Shortages Hit Record Levels : Requesting a refill at the local pharmacy or getting a complete series of a specific chemotherapy is becoming ...
webmd.com/drug-medication/news/20240418/national-drug-shortages-hit-record-levels
Abeona shares tumble as FDA declines to approve skin disorder treatment: Abeona Therapeutics said on Monday the U.S. Food and Drug Administration (FDA) had ...
reuters.com/business/healthcare-pharmaceuticals/us-fda-declines-approve-abeonas-skin-disorder-treatment-2024-04-22/
Eli Lilly to acquire manufacturing facility from Nexus Pharma: Eli Lilly said on Monday that it will acquire a manufacturing facility from Nexus Pharmaceuticals ...
reuters.com/business/healthcare-pharmaceuticals/eli-lilly-acquire-manufacturing-facility-nexus-pharma-2024-04-22/
Most nursing homes don't have enough staff to meet the federal government's new rules
npr.org/sections/health-shots/2024/04/24/1246628171/nursing-home-staffing-final-rule-medicare-medicaid
Quick Glance: Biden's Landmark Staffing Mandate for Nursing Homes
- The Biden administration has implemented first-ever staffing requirements for nursing homes to enhance care quality.
- The rule mandates 24/7 registered nurses and a minimum of 3.48 hours of care per resident daily.
- Industry voices concerns over staff shortages, estimating a need for over 100,000 additional workers.
- The new regulations will be phased in and could potentially lead to facility closures for non-compliance.
Gilead posts quarterly loss on acquisition charge, revenue rises 5%: Gilead Sciences reported a first-quarter loss on Thursday after taking a $3 ...
reuters.com/business/healthcare-pharmaceuticals/gilead-posts-quarterly-loss-revenue-rises-5-2024-04-25/
Alzheimer’s drug Leqembi falls short of blockbuster status in faltering US rollout
ft.com/content/1e02c10c-f7c4-48e9-a6a4-774531b56350
Eli Lilly weight-loss drug found to address sleep apnoea in trial: Study results could encourage US Medicare system and private insurers to cover tirzepatide ...
ft.com/content/1c7e2db2-1bfd-4882-96d6-b53795844a1b
Science is closing in on the frailties of old age: Research is finding way to extend animal lifespans but regulators are still wary of treating ageing as a ...
ft.com/content/bb0a8eb7-227a-400a-919a-ab7dd2f20f0b
How Addiction and Alcoholism Affected My Romantic Relationships: I’m going to go a little bit deep on this one, as it is personally a quite timely piece for me ...
blogs.webmd.com/substance-abuse/20211122/how-addiction-and-alcoholism-affected-my-romantic-relationships
Woman Suddenly Loses Medicare Insurance in Middle of Cancer Treatment: The 67-year-old Charlotte resident said she was undergoing treatment for her stage 4 ...
newsweek.com/woman-loses-medicare-insurance-during-cancer-treatment-1893939
Most of Lilly's Mounjaro and Zepbound doses in limited supply, FDA says: The U.S. Food and Drug Administration website showed that most doses of Eli Lilly's ...
reut.rs/4d1SgqR
Most nursing homes don't have enough staff to meet the federal government's new rules
npr.org/sections/health-shots/2024/04/24/1246628171/nursing-home-staffing-final-rule-medicare-medicaid
India's Biocon developing its own version of Wegovy, clinical trial likely next year
reuters.com/business/healthcare-pharmaceuticals/indias-biocon-developing-its-own-version-wegovy-clinical-trial-likely-next-year-2024-04-18/
Quick Glance: Biocon Developing Own Version of Wegovy, Plans Clinical Trial
- Indian pharmaceutical company Biocon is working on developing its own version of Novo Nordisk's popular Wegovy and is likely to conduct a clinical trial next year to enter the growing weight-loss drug market.
- Biocon's CEO, Siddharth Mittal, has expressed the company's intention to develop semaglutide, the active ingredient in Wegovy, for the Indian market, even if it requires a clinical trial.
- Biocon aims to introduce generic versions of weight-loss drugs in emerging markets such as Brazil, Mexico, and Saudi Arabia before the patent for semaglutide expires in those countries in 2026.
- The company is striving to obtain a waiver on clinical trials from Indian regulators and submit bioequivalence studies to demonstrate the effectiveness of their version of semaglutide. Biocon is making significant investments in generics research and development, including peptides for weight-loss drugs.
Mayo Clinic RegenBio Summit 2024 registration opens, keynotes announced: Registration is open and keynote speakers for Mayo Clinic RegenBio Summit 2024 include ...
newsnetwork.mayoclinic.org/discussion/mayo-clinic-regenbio-summit-2024-registration-opens-keynotes-announced/
Some Older Women Need Extra Breast Scans. Why Won’t Medicare Pay?: Mammography can miss tumors in women with dense breasts, so their doctors often include ...
nytimes.com/2024/04/19/health/dense-breast-mammograms-medicare.html
Pre-Ozempic Obesity Drugs: Effective and Budget-Friendly: Before there was Ozempic, there were these cost-friendly, safe, and highly effective weight loss drugs ...
webmd.com/obesity/news/20240426/pre-ozempic-obesity-drugs-effective-and-less-costly
Bogus Botox poisoning outbreak spreads to 9 states, CDC says: All of the case have been in women, nine of whom were hospitalized.
arstechnica.com/science/2024/04/bogus-botox-poisoning-outbreak-spreads-to-9-states-cdc-says/
The weight loss drug Ozempic is not linked to suicidal thoughts, regulators say: The European Medicines Agency announced the findings of its nine-month review
qz.com/ema-ozempic-suicidal-thoughts-1851406145
U.S. Supreme Court rejects Vanda Pharmaceuticals case over sleep-drug patents: The U.S. Supreme Court on Monday declined to hear a bid by Vanda Pharmaceuticals ...
reuters.com/legal/us-supreme-court-rejects-vanda-pharmaceuticals-case-over-sleep-drug-patents-2024-04-22/
Neumora's early-stage schizophrenia drug study put on hold: Neumora Therapeutics said on Monday the U.S. Food and Drug Administration (FDA) had placed a clinical ...
reut.rs/49wLNBq
Medicare ignored expert advice to cut tests for transplant patients: Report: Contractors for the Centers for Medicare and Medicaid Services (CMS) cut access to ...
thehill.com/policy/healthcare/4606446-medicare-ignored-expert-advice-to-cut-tests-for-transplant-patients/
FDA and USDA food recalls reach highest level since before pandemic: Undeclared allergen, Listeria and Salmonella were the top three reasons for food recalls in ...
axios.com/2024/04/25/food-recall-usda-fda-recalls
What to know about Zyn, the tiny nicotine pouch that's sparked a big health debate
apnews.com/article/zyn-pouches-nicotine-smoking-teenagers-fda-424a020348cdc6495684272a2a671c6a
FDA classifies recall of Boston Scientific device as 'most serious': The U.S. Food and Drug Administration on Wednesday classified a recall of Boston ...
reuters.com/business/healthcare-pharmaceuticals/fda-classifies-recall-boston-scientific-device-treat-hemorrhaging-most-serious-2024-04-17/
Bullish signal for biotech shares: Will this solve one of Novo Nordisk's biggest problems?
boerse-online.de/nachrichten/aktien/bullisches-signal-fuer-biotech-aktie-loest-das-eines-der-groessten-probleme-von-novo-nordisk-20355342.html
We've started using a recently FDA-approved ultrasound device to treat liver tumors.
The noninvasive technology uses brief high-intensity ultrasound pulses to ...
cle.clinic/4askbih
Medicare beneficiaries could be eligible for Wegovy coverage, study shows
reuters.com/business/healthcare-pharmaceuticals/about-36-mln-medicare-beneficiaries-could-be-eligible-wegovy-coverage-study-2024-04-24/
3.6 million Medicare enrollees may now be eligible for Wegovy coverage: About 3.6 million Medicare enrollees may qualify for coverage for the anti-obesity drug ...
cnn.com/2024/04/24/health/wegovy-medicare-spending/
US FDA warns of harmful reactions to fake Botox injections: The U.S. Food and Drug Administration on Tuesday alerted health care professionals and consumers that ...
reuters.com/business/healthcare-pharmaceuticals/us-fda-warns-harmful-reactions-fake-botox-injections-2024-04-16/
It's the first drug shown to slow Alzheimer's. Why is is it off to a slow start?: The first drug shown to slow Alzheimer’s hit the U.S. market over a year ago ...
apnews.com/article/alzheimer-leqembi-slow-start-f9022b85b16cc6de4491594ce875657b
Eli Lilly to Ask FDA to Approve Weight Loss Drug for Sleep Apnea: Preliminary clinical trial results showed the obesity drug tirzepatide was highly effective at ...
wb.md/3Q5isqO
Ozempic use appears to be changing people's personalities —experts think they know why
nypost.com/2024/04/17/lifestyle/experts-reveal-why-ozempic-appears-to-change-peoples-personalities/
Trump had 4 years to remake Obamacare. Here’s what he did: Instead of terminating the Affordable Care Act, former President Donald Trump is now promising to make ...
cnn.com/2024/04/12/politics/obamacare-trump-administration/
Trader Joe's recalls basil from shelves in 29 states after salmonella outbreak: Trader Joe's recalled organic basil and the FDA is investigating after customers ...
usatoday.com/story/money/food/2024/04/18/trader-joes-recall-2024-basil-salmonella/73375663007/
Why Is There a Tick Vaccine For Dogs and Not Humans?: Certain concerns have hindered development, but several Lyme prevention drugs are currently being tested in ...
nytimes.com/2024/04/16/well/live/humans-dogs-vaccine-lyme-disease.html
Neurotech startup Neurovalens gets FDA clearance for non-invasive anxiety treatment
techcrunch.com/2024/04/08/neurovalens-anxiety-fda/
FDA head pushes for mandated lead testing by food manufacturers: The head of the U.S. Food and Drug Administration (FDA), Dr. Robert Califf ...
trib.al/29j5sol
After Recall, Philips Must Launch New Safeguards in DOJ Agreement: The settlement comes nearly three years after the company acknowledged that an industrial foam ...
propublica.org/article/after-recall-philips-must-launch-new-safeguards-in-doj-agreement
Paxlovid COVID Treatment Is Most Beneficial for Unvaccinated People with Risk Factors. Others May Not Need It
scientificamerican.com/article/paxlovid-covid-treatment-most-beneficial-for-unvaccinated-people-with-risk/
Asthma Inhaler Chaos Leaves Us Doctors and the Children We Treat Out of Breath: The go-to asthma inhaler prescribed by pediatricians for decades has been ...
usnews.com/opinion/articles/2024-04-18/asthma-inhaler-chaos-leaves-us-doctors-and-the-children-we-treat-out-of-breath
Ozempic ‘oops’ babies spark debate about weight-loss shot use as fertility drugs: A surprising thing is happening to some women on weight-loss drugs who’ve ...
bostonherald.com/2024/04/22/ozempic-oops-babies-spark-debate-about-weight-loss-shot-use-as-fertility-drugs/
Eli Lilly's weight loss drug Zepbound found to reduce sleep apnea, company says: Eli Lilly’s weight loss drug Zepbound was found to reduce obstructive sleep ...
nbcnews.com/health/health-news/eli-lillys-weight-loss-drug-zepbound-found-reduce-sleep-apnea-company-rcna148113
Hospital emissions reporting proposal is a "game changer": Hospitals could soon give the federal health department a closer look at their emissions.
axios.com/2024/04/22/hospitals-climate-change-emissions-medicare
Study: Many cancer drugs unproven 5 years after accelerated approval: Researchers have found that most cancer drugs granted accelerated approval by the U.S ...
apnews.com/article/cancer-drugs-fda-accelerated-approval-d5adffd124e0d038a8fd0357ced59546
Abortion opponents still expect federal action from Trump. Here’s what it could look like.
washingtonpost.com/politics/2024/04/10/trump-abortion-federal-action/
Quick Glance: Arizona Republicans Block Efforts to Repeal 1864 Abortion Ban
- Democratic bills to repeal a 160-year-old abortion ban were blocked in the Legislature.
- Arizona's highest court decision upholding a 1864 abortion ban caused chaos and confusion.
- Democrats aimed to repeal the ban to protect women's health, facing hurdles in the Republican-controlled legislature.
- The uncertainty loomed over whether Republican leaders would allow immediate action on repealing the ban, despite pressure from Democrats and some Republicans.
Harrow CEO tries to defend 486% price hike of eye medication: In February, Harrow increased the price of its eye medication, Triesence, by 486% to $944 from $161
qz.com/harrow-triesence-price-hike-1851401621
Adderall Abuse Risks Becoming Another Opioid Crisis, DEA Says: The fast rise of prescriptions for Adderall and other stimulants, along with rampant online ...
bloomberg.com/news/articles/2024-04-19/adderall-abuse-risks-becoming-another-opioid-crisis-dea-says
EU regulator to review reports of suicidal thoughts and weight loss drugs: A European Medicines Agency committee will this week hold a meeting related to its ...
reuters.com/business/healthcare-pharmaceuticals/eu-health-regulator-discuss-any-link-between-weight-loss-drugs-suicidal-thoughts-2024-04-08/
Bird Flu Virus Remnants Found In U.S. Milk Supply—FDA Says Milk Remains Safe: A large outbreak of bird flu in dairy cows as reported late last month.
forbes.com/sites/antoniopequenoiv/2024/04/23/bird-flu-virus-remnants-found-in-us-milk-supply-fda-says-milk-remains-safe/
FDA Recalls Heart Pumps Linked to Deaths and Injuries: Two medical devices that mechanically pump blood to the heart have caused hundreds of injuries and more ...
scientificamerican.com/article/fda-recalls-heart-pumps-linked-to-deaths-and-injuries/
Bird flu virus found in pasteurized milk, though officials maintain supply is safe
nbcnews.com/health/health-news/bird-flu-virus-found-pasteurized-milk-though-officials-maintain-supply-rcna149084
Novo Nordisk may buy German biotech company Cardior: The German biotech company Cardior is researching an active ingredient against heart failure and is now ...
diepresse.com/18385607/novo-nordisk-darf-deutsche-biotech-firma-cardior-kaufen
Fake Botox has sickened patients nationwide. Here's what to know — and what to avoid
npr.org/2024/04/19/1245519732/fake-botox-tips-avoiding-illness-hospitalization
Greg Abbott Issues Dire Warning Over Medicaid Changes: The Texas governor urged Joe Biden to "abandon his new Medicaid policies" and warned they could "devastate ...
newsweek.com/greg-abbott-warning-joe-biden-medicaid-changes-texas-1889697
UPSC topper Aditya Srivastava reveals 2 key reasons why he didn’t go abroad: brain drain and ageing parents
hindustantimes.com/trending/upsc-topper-aditya-srivastava-reveals-2-key-reasons-why-he-didn-t-go-abroad-brain-drain-and-ageing-parents-101713279933123.html
Quick Glance: Pune students shine in UPSC results
- UPSC aspirants from Pune have secured high ranks in the most coveted civil services examination conducted by the Union Public Services Commission.
- Tejas Sudeep Sarda, a doctor, took a break from his career to prepare for UPSC, securing an AIR of 128.
- Priyanka Mohite from Nashik, who completed her master's in political science at Pune University, secured an AIR of 595.
- Abhijit Pakhare, a 26-year-old deputy collector in Gadchiroli, did not give up on his dream of clearing the UPSC exam, securing the 720th rank.
Would you risk a breakdown to cure baldness?: Thousands of men claim that finasteride has given them devastating and long-lasting side-effects
economist.com/1843/2024/04/05/would-you-risk-a-breakdown-to-cure-baldness
Amid syphilis surge, doctors call for more testing during pregnancy: A coalition of obstetricians is recommending routine blood screening at the first prenatal ...
washingtonpost.com/health/2024/04/18/screening-syphilis-baby-pregnant/
Why homeless people are losing health coverage in Medicaid mix-ups : Nearly 130,000 Montanans lost Medicaid coverage during recent eligibility reviews ...
npr.org/sections/health-shots/2024/04/16/1244000356/homeless-health-medicaid-uninsured-kicked-off-redetermination-disenrolled
The drug war devastated Black and other minority communities. Is marijuana legalization helping?
omaha.com/news/nation-world/marijuana-legalization-us-drug-war-blacks-minorities-social-equity-enforcement/article_f880fcae-75bf-5ae9-9894-f04981256b45.html
Bausch wins US appeal to block Alvogen generic of diarrhea drug: A U.S. appeals court on Thursday affirmed a decision for Bausch Health that barred rival ...
reuters.com/business/healthcare-pharmaceuticals/bausch-wins-us-appeal-block-alvogen-generic-diarrhea-drug-2024-04-11/
US FDA declines to approve Supernus' Parkinson's combination again: Supernus Pharmaceuticals said on Monday the U.S. FDA declined to approve its drug-device ...
reuters.com/business/healthcare-pharmaceuticals/us-fda-declines-approve-supernus-drug-device-combination-parkinsons-disease-2024-04-08/
Next
New to NewsWall?
Sign up now to get your own personalized news!
Trending topics